Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹28497 Cr.
Stock P/E
117.8
P/B
7.5
Current Price
₹678.5
Book Value
₹ 90.1
Face Value
2
52W High
₹858.2
52W Low
₹ 575.6
Dividend Yield
0%

Krishna Inst.Medi Overview

Business

Krishna Institute of Medical Sciences Ltd (KIMS) is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana, with a growing presence in Karnataka and Maharashtra. The company operates a chain of multi-specialty hospitals offering comprehensive tertiary and quaternary healthcare services. KIMS provides a wide range of medical services across specialties like cardiac sciences, oncology, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, and mother & child care. Its core business model revolves around providing inpatient and outpatient medical treatment, surgical procedures, diagnostics, and pharmacy services, generating revenue directly from patients, insurance companies, and government schemes.

Revenue Mix

KIMS primarily operates within the 'Hospital & Healthcare Services' industry. Its revenue is predominantly derived from its multi-specialty hospital operations. The major components of its revenue mix include:

Medical Services: Inpatient and outpatient consultations, treatments, surgeries, and procedures across various specialties.

Diagnostics: Laboratory tests, imaging services (MRI, CT scans, X-rays).

Pharmacy Sales: Revenue from in-hospital pharmacies.

While specific percentage breakdowns are not publicly available in detail, medical services constitute the bulk of its revenue.

Industry

The Indian healthcare industry is characterized by significant growth, driven by an aging population, rising disposable incomes, increasing health awareness, growing prevalence of lifestyle diseases, and expanding health insurance penetration. The industry is fragmented, with both organized corporate chains and a large number of standalone hospitals and clinics. KIMS is positioned as a leading regional corporate healthcare provider, particularly strong in Andhra Pradesh and Telangana. It competes with other large national and regional hospital chains (e.g., Apollo, Fortis, Max Healthcare, Aster DM) as well as smaller local hospitals. KIMS focuses on providing quality multi-specialty care at relatively affordable price points, aiming for operational efficiency and patient volume.

MOAT

Regional Scale & Brand Reputation: KIMS has established a strong brand name and significant market share in its core geographies of Andhra Pradesh and Telangana, building trust and recognition among patients and referring physicians.

Doctor Relationships: Long-standing relationships with a strong panel of experienced doctors and consultants are crucial in healthcare and contribute to patient loyalty.

Operational Efficiency: The company has demonstrated a focus on operational efficiency, which helps maintain competitive pricing and profitability.

Network Effect (within region): A growing network of hospitals within its primary operating regions allows for better patient referrals and resource optimization.

Growth Drivers

Increasing Demand for Healthcare: Driven by demographics (aging population, rising chronic diseases), urbanization, and growing health insurance coverage.

Expansion in Existing & New Geographies: Both brownfield (capacity expansion in existing hospitals) and greenfield (new hospital construction) expansion, along with strategic acquisitions, are key to growth. KIMS has been expanding beyond its core regions.

Medical Value Travel: India's growing appeal as a destination for medical tourism presents an opportunity for KIMS to attract international patients.

Focus on High-Value Specialties: Continued investment and strengthening of specialties like organ transplantation, oncology, and cardiac sciences that command higher revenue per patient.

Digital Health Integration: Leveraging technology for patient engagement, telemedicine, and operational efficiency.

Risks

Regulatory & Pricing Pressure: Government interventions like price caps on medical procedures (e.g., stents, knee implants) or Ayushman Bharat scheme tariffs can impact profitability. Changes in health insurance regulations also pose a risk.

Intense Competition: The healthcare sector is highly competitive, potentially leading to pricing pressure and challenges in attracting and retaining medical talent.

Doctor & Staff Attrition: Reliance on key medical professionals means a loss of critical doctors can impact patient volumes and reputation. Rising staff costs are also a concern.

High Capital Expenditure: Expanding the hospital network requires significant capital investment, leading to potential debt accumulation and execution risks.

Litigation & Medical Malpractice: The inherent risk of medical errors leading to legal challenges and reputational damage.

Economic Downturns: Can impact affordability for elective procedures and overall patient footfall.

Management & Ownership

KIMS is a promoter-led company. Dr. Bhaskar Rao, a renowned cardiothoracic surgeon, is the founder, Chairman, and Managing Director, playing a pivotal role in the company's growth and strategic direction. The management team generally comprises experienced professionals with a strong understanding of the healthcare delivery model in India. The ownership structure includes the promoter group holding a significant stake, along with institutional investors (domestic and foreign) and public shareholders. The promoter's strong medical background and long-standing experience in hospital management are key strengths.

Outlook

KIMS is well-positioned to capitalize on the robust growth in the Indian healthcare sector, driven by increasing demand and evolving patient needs. Its established brand equity and strong network in its core markets provide a solid foundation. The company's strategy of calibrated expansion into new geographies and focus on operational efficiency should support future growth. However, the outlook is balanced by inherent industry risks, including potential regulatory price controls, intense competition for talent and patients, and the high capital expenditure required for sustained growth. Successfully integrating new acquisitions and managing cost pressures will be crucial for maintaining its profitability and market position.

Krishna Inst.Medi Share Price

Live · BSE / NSE · Inception: 1973
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Krishna Inst.Medi Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 634 688 777 772 797 872 961 998 1075 1180
Other Income 4 5 5 18 5 7 4 5 10 16
Total Income 638 693 782 790 801 879 965 1003 1084 1196
Total Expenditure 475 509 559 585 599 679 757 799 868 956
Operating Profit 163 184 223 205 203 200 208 204 216 240
Interest 16 18 20 26 27 33 45 57 68 83
Depreciation 46 39 41 45 53 53 66 79 85 101
Exceptional Income / Expenses 0 0 0 0 11 0 -0 0 -11 0
Profit Before Tax 100 127 162 135 134 114 97 69 52 56
Provision for Tax 29 32 42 42 28 29 25 17 22 19
Profit After Tax 72 95 121 93 106 85 72 52 31 36
Adjustments -6 -9 -13 -4 -4 -6 -5 2 12 5
Profit After Adjustments 66 87 107 89 102 79 67 53 43 42
Adjusted Earnings Per Share 1.6 2.2 2.7 2.2 2.5 2 1.7 1.3 1.1 1

Krishna Inst.Medi Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 512 567 664 918 1123 1330 1651 2198 2498 3035 3905 4214
Other Income 5 3 34 6 6 10 20 37 16 32 26 35
Total Income 516 570 698 924 1129 1340 1671 2235 2514 3067 3931 4248
Total Expenditure 403 508 592 833 873 954 1129 1598 1854 2242 3090 3380
Operating Profit 113 63 106 90 256 386 542 637 661 825 841 868
Interest 37 80 88 49 44 37 22 37 55 100 215 253
Depreciation 35 36 40 56 71 70 73 129 147 177 283 331
Exceptional Income / Expenses 0 0 0 0 0 0 0 15 0 11 -11 -11
Profit Before Tax 41 -53 -22 -15 141 279 457 485 460 558 334 274
Provision for Tax 13 18 26 34 25 74 113 119 124 143 92 83
Profit After Tax 28 -71 -48 -49 115 205 344 366 336 415 242 191
Adjustments -1 -0 1 1 4 -4 -11 -29 -26 -30 -1 14
Profit After Adjustments 27 -71 -47 -48 119 201 333 336 310 385 241 205
Adjusted Earnings Per Share 0.8 -2.8 -1.9 -1.3 3.2 5.2 8.3 8.4 7.8 9.6 6 5.1

Krishna Inst.Medi Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 263 -113 -158 541 598 864 1387 1670 1828 2138 2247
Minority's Interest 7 5 21 25 13 12 23 268 265 281 311
Borrowings 174 199 249 243 269 185 138 497 928 1654 2673
Other Non-Current Liabilities 47 45 53 104 96 94 141 169 347 767 1161
Total Current Liabilities 174 629 745 201 219 278 215 296 452 836 1239
Total Liabilities 665 764 910 1114 1194 1433 1904 2901 3820 5676 7631
Fixed Assets 515 523 711 863 916 931 1005 1766 2434 3349 5710
Other Non-Current Assets 35 96 43 77 59 51 506 657 839 1630 984
Total Current Assets 115 146 156 174 220 451 393 478 547 697 937
Total Assets 665 764 910 1114 1194 1433 1904 2901 3820 5676 7631

Krishna Inst.Medi Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 14 3 8 11 8 41 52 26 62 47 56
Cash Flow from Operating Activities 95 83 106 134 202 356 324 432 521 582 511
Cash Flow from Investing Activities -41 -70 -64 -110 -125 -354 -412 -547 -753 -1116 -1452
Cash Flow from Financing Activities -65 -8 -39 -27 -44 10 61 20 217 543 940
Net Cash Inflow / Outflow -11 5 3 -3 32 12 -26 -95 -15 9 -1
Closing Cash & Cash Equivalent 3 8 11 8 41 52 26 62 47 56 55

Krishna Inst.Medi Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 0.76 -2.84 -1.88 -1.28 3.2 5.19 8.31 8.41 7.75 9.61 6.04
CEPS(Rs) 1.8 -1.39 -0.32 0.2 4.99 7.09 10.41 12.37 12.06 14.8 13.13
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 7.48 -4.51 -6.31 14.51 16.05 22.26 34.67 41.72 45.71 53.45 56.19
Core EBITDA Margin(%) 21.27 10.49 10.76 9.22 22.22 28.25 31.6 27.27 25.81 26.13 20.86
EBIT Margin(%) 15.23 4.73 9.97 3.74 16.48 23.79 29 23.76 20.57 21.7 14.06
Pre Tax Margin(%) 7.99 -9.33 -3.31 -1.64 12.52 20.98 27.67 22.06 18.39 18.39 8.55
PAT Margin (%) 5.47 -12.48 -7.2 -5.29 10.25 15.45 20.83 16.65 13.45 13.67 6.2
Cash Profit Margin (%) 12.4 -6.14 -1.23 0.82 16.54 20.68 25.23 22.53 19.31 19.51 13.45
ROA(%) 4.23 -9.91 -5.71 -4.8 9.97 15.64 20.6 15.23 10 8.74 3.64
ROE(%) 11.15 -94.27 0 -25.44 20.22 28.12 30.55 23.93 19.21 20.92 11.04
ROCE(%) 14.96 5.18 12.42 4.99 21.17 30.82 35.69 27.84 20.25 19.02 11.51
Receivable days 37.01 47.56 51.94 45.88 41.54 33.22 26.36 31.66 39.96 41.48 44.38
Inventory Days 8.4 9.24 10.05 9.34 9.3 7.47 6.69 6.58 6.74 6.82 7.52
Payable days 186.41 192.4 196.7 172.78 163.35 161.26 134.33 115.35 127.64 135.6 133.54
PER(x) 0 0 0 0 0 0 33.2 33.46 53.11 66.51 103.16
Price/Book(x) 0 0 0 0 0 0 7.96 6.74 9.01 11.96 11.08
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.62 1.18 1.12 0.38 0.31 0.05 6.67 5.33 6.99 9.03 7.19
EV/Core EBITDA(x) 2.81 10.69 7.05 3.89 1.37 0.16 20.33 18.41 26.43 33.22 33.39
Net Sales Growth(%) 21.95 10.81 17.02 38.32 22.29 18.46 24.13 33.13 13.67 21.49 28.65
EBIT Growth(%) 58.49 -65.61 146.73 -48.04 438.28 71.03 51.33 9.08 -1.57 28.11 -16.63
PAT Growth(%) 288.58 -353.08 32.49 -1.66 336.84 78.57 67.31 6.4 -8.18 23.49 -41.66
EPS Growth(%) 374.56 -475.97 33.83 31.98 350.09 62.08 60.3 1.09 -7.79 24.03 -37.22
Debt/Equity(x) 0.97 -5.56 -4.47 0.53 0.54 0.31 0.12 0.32 0.57 0.89 1.44
Current Ratio(x) 0.66 0.23 0.21 0.87 1 1.62 1.83 1.61 1.21 0.83 0.76
Quick Ratio(x) 0.59 0.21 0.18 0.73 0.87 1.53 1.66 1.47 1.1 0.76 0.68
Interest Cover(x) 2.1 0.34 0.75 0.7 4.16 8.47 21.89 14.01 9.43 6.56 2.55
Total Debt/Mcap(x) 0 0 0 0 0 0 0.01 0.05 0.06 0.07 0.13

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +29% +21% +24% +23%
Operating Profit CAGR +2% +10% +17% +22%
PAT CAGR -42% -13% +3% +24%
Share Price CAGR -6% +20% +25% —
ROE Average +11% +17% +21% +4%
ROCE Average +12% +17% +23% +19%

Krishna Inst.Medi Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 32.5 %
FII 14.74 %
DII (MF + Insurance) 34.31 %
Public (retail) 18.45 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 38.8238.8238.8238.8238.8234.1134.1134.1134.1132.5
FII 16.7317.8415.8515.6815.4515.5415.0314.3314.5714.74
DII 33.1332.1232.332.0531.9531.6532.1232.6132.3834.31
Public 11.3211.2213.0313.4513.7818.6918.7518.9518.9418.45
Others 0000000000
Total 100100100100100100100100100100

Krishna Inst.Medi Peer Comparison

Hospital & Healthcare Services Edit Columns

Krishna Inst.Medi Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Krishna Inst.Medi Pros & Cons

Pros

  • Debtor days have improved from 135.6 to 133.54days.

Cons

  • Promoter holding is low: 32.5%.
  • Stock is trading at 7.5 times its book value.
  • The company has delivered a poor profit growth of 3% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp